Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.

Impact of Chemotherapy Delay on Overall Survival for AML with IDH1/2 Mutations: A Study in Adult Chinese Patients.

The effect of time from diagnosis to treatment (TDT) on overall survival of patients with acute myeloid leukemia (AML) remains obscure. Furthermore, whether chemotherapy delay impacts overall survival (OS) of patients with a special molecular subtype has not been investigated. Here, we enrolled 364...

Full description

Bibliographic Details
Main Authors: Jing-Han Wang, Qi Guo, Zhi-Xin Ma, Qiu-Ling Ma, Meng-Xia Yu, Xiu-Feng Yin, Sha-Sha Lu, Hong-Qiong Xie, Yue-Hong Jiang, Dan Shen, Li-Ya Ma, Hui Shi, Wen-Juan Yu, Ye-Jiang Lou, Ying Li, Min Yang, Gai-Xiang Xu, Li-Ping Mao, Jian-Hu Li, Huan-Ping Wang, Dong-Mei Wang, Ju-Ying Wei, Hong-Yan Tong, Jian Huang, Jie Jin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4605653?pdf=render

Internet

http://europepmc.org/articles/PMC4605653?pdf=render

Similar Items